Bulletin
Investor Alert

New York Markets Close in:

Elanco Animal Health Inc.

NYS: ELAN

GO
/marketstate/country/us

Countdown to close

 --Real time quotes

Oct 25, 2021, 3:45 p.m.

/zigman2/quotes/203710302/composite

$

33.92

Change

+0.01 +0.04%

Volume

Volume 866,734

Real time quotes

/zigman2/quotes/203710302/composite

Previous close

$ 33.90

$ 33.92

Change

+0.01 +0.04%

Day low

Day high

$33.69

$34.19

Open

52 week low

52 week high

$26.72

$37.49

Open

Insider Actions for Elanco Animal Health Inc.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
08/16/2021 R. David Hoover
See Remarks; Director
8,000   Acquisition at $31.45 per share. 251,600
08/13/2021 R. David Hoover
See Remarks; Director
2,000   Acquisition at $30.74 per share. 61,480
08/11/2021 Jeffrey N. Simmons
President, CEO & Director; Director
16,850   Acquisition at $29.7 per share. 500,445
08/11/2021 Michael J. Harrington
Director
3,000   Acquisition at $28.98 per share. 86,940
07/01/2021 Racquel Harris Mason
See Remarks
1,933   Derivative/Non-derivative trans. at $35 per share. 67,655
07/01/2021 De Simas Jose Manuel Correia
See Remarks
1,425   Derivative/Non-derivative trans. at $35 per share. 49,875
07/01/2021 Marcela A. Kirberger
See Remarks
8,572   Award at $0 per share. 0
06/03/2021 James M. Meer
Chief Accounting Officer
70   Derivative/Non-derivative trans. at $35 per share. 2,450
05/11/2021 R. David Hoover
See Remarks; Director
25,000   Acquisition at $32.44 per share. 811,000
05/11/2021 Art A. Garcia
Director
1,525   Acquisition at $32.88 per share. 50,142
03/05/2021 Jeffrey N. Simmons
President, CEO & Director; Director
74,374   Award at $0 per share. 0
03/02/2021 Jeffrey N. Simmons
President, CEO & Director; Director
8,879   Derivative/Non-derivative trans. at $32.34 per share. 287,146
03/02/2021 David S. Kinard
See Remarks
573   Derivative/Non-derivative trans. at $32.34 per share. 18,530
03/02/2021 Aaron L. Schacht
See Remarks
1,166   Derivative/Non-derivative trans. at $32.34 per share. 37,708
03/02/2021 Todd S. Young
See Remarks
1,723   Derivative/Non-derivative trans. at $32.34 per share. 55,721
03/02/2021 David Urbanek
See Remarks
630   Derivative/Non-derivative trans. at $32.34 per share. 20,374
03/02/2021 Ramiro M. Cabral
See Remarks
820   Derivative/Non-derivative trans. at $32.34 per share. 26,518
03/02/2021 Michael-Bryant Hicks
See Remarks
880   Derivative/Non-derivative trans. at $32.34 per share. 28,459
03/02/2021 James M. Meer
Chief Accounting Officer
337   Derivative/Non-derivative trans. at $32.34 per share. 10,898
03/01/2021 Jeffrey N. Simmons
President, CEO & Director; Director
4,883   Derivative/Non-derivative trans. at $33.65 per share. 164,312
03/01/2021 David S. Kinard
See Remarks
483   Derivative/Non-derivative trans. at $33.65 per share. 16,252
03/01/2021 Aaron L. Schacht
See Remarks
502   Derivative/Non-derivative trans. at $33.65 per share. 16,892
03/01/2021 Todd S. Young
See Remarks
949   Derivative/Non-derivative trans. at $33.65 per share. 31,933
03/01/2021 David Urbanek
See Remarks
425   Derivative/Non-derivative trans. at $33.65 per share. 14,301
03/01/2021 Ramiro M. Cabral
See Remarks
334   Derivative/Non-derivative trans. at $33.65 per share. 11,239
03/01/2021 Michael-Bryant Hicks
See Remarks
799   Derivative/Non-derivative trans. at $33.65 per share. 26,886
03/01/2021 James M. Meer
Chief Accounting Officer
84   Derivative/Non-derivative trans. at $33.65 per share. 2,826
03/01/2021 David S. Kinard
See Remarks
6,717   Award at $0 per share. 0
03/01/2021 Aaron L. Schacht
See Remarks
13,812   Award at $0 per share. 0
03/01/2021 Todd S. Young
See Remarks
15,669   Award at $0 per share. 0
03/01/2021 David Urbanek
See Remarks
7,876   Award at $0 per share. 0
03/01/2021 Ramiro M. Cabral
See Remarks
9,503   Award at $0 per share. 0
03/01/2021 Joyce J. Lee
Ex VP Prs US Pet Hlth Com Op
8,492   Award at $0 per share. 0
03/01/2021 Racquel Harris Mason
See Remarks
4,466   Award at $0 per share. 0
03/01/2021 De Simas Jose Manuel Correia
See Remarks
3,552   Award at $0 per share. 0
03/01/2021 Dirk Ehle
Ex VP & Pres Elanco Europe
2,792   Award at $0 per share. 0
03/01/2021 James M. Meer
Chief Accounting Officer
2,972   Award at $0 per share. 0
02/22/2021 Jeffrey N. Simmons
President, CEO & Director; Director
39,180   Derivative/Non-derivative trans. at $30.58 per share. 1,198,124
02/22/2021 David S. Kinard
See Remarks
3,870   Derivative/Non-derivative trans. at $30.58 per share. 118,344
02/22/2021 Aaron L. Schacht
See Remarks
4,025   Derivative/Non-derivative trans. at $30.58 per share. 123,084
02/22/2021 Todd S. Young
See Remarks
7,722   Derivative/Non-derivative trans. at $30.58 per share. 236,138
02/22/2021 David Urbanek
See Remarks
3,406   Derivative/Non-derivative trans. at $30.58 per share. 104,155
02/22/2021 Ramiro M. Cabral
See Remarks
2,675   Derivative/Non-derivative trans. at $30.58 per share. 81,801
02/22/2021 Michael-Bryant Hicks
See Remarks
6,533   Derivative/Non-derivative trans. at $30.58 per share. 199,779
02/22/2021 James M. Meer
Chief Accounting Officer
671   Derivative/Non-derivative trans. at $30.58 per share. 20,519
02/22/2021 Jeffrey N. Simmons
President, CEO & Director; Director
89,902   Award at $0 per share. 0
02/22/2021 David S. Kinard
See Remarks
13,540   Award at $0 per share. 0
02/22/2021 Aaron L. Schacht
See Remarks
14,082   Award at $0 per share. 0
02/22/2021 Todd S. Young
See Remarks
25,996   Award at $0 per share. 0
02/22/2021 David Urbanek
See Remarks
11,916   Award at $0 per share. 0
02/22/2021 Ramiro M. Cabral
See Remarks
9,359   Award at $0 per share. 0
02/22/2021 Michael-Bryant Hicks
See Remarks
21,663   Award at $0 per share. 0
02/22/2021 James M. Meer
Chief Accounting Officer
1,950   Award at $0 per share. 0

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
4 Purchases
0 Sales
29,850
0
Last 6 months
7 Purchases
3 Sales
64,947
3,428
Last 12 months
35 Purchases
34 Sales
456,545
164,288

Officers and Executives

Mr. Jeffrey N. Simmons
President, Chief Executive Officer & Director
Mr. Todd S. Young
CFO & EVP-Corporate Governance & Strategy
Mr. Shabbir Simjee
Chief Medical Officer
Mr. Christopher Keeley
Chief Information Officer & Senior Vice President
Mr. David S. Kinard
EVP-Human Resources Corporate Affairs
Ms. Julie Lawless
Vice President-Corporate Affairs & Administration
Dr. Sara Place
Chief Sustainability Officer
Ms. Michelle Calvo-Lorenzo
Chief Animal Welfare Officer
Dr. Dirk Ehle
Executive Vice President & President-Elanco Europe
Dr. Terry J. Opgenorth
Partner
Mr. Roy Riggs
Director-Dairy Business Unit
Mr. Ramiro M. Cabral
Executive Vice President-Elanco International
Mr. Lucas E. Montarce
Vice President
Mr. Aaron L. Schacht
Executive VP-Business Development
Mr. David Urbanek
Executive Vice President-Manufacturing & Quality
Ms. Genefer Douglass
Senior Director-Ethics & Compliance
Mr. Michael J. Harrington
Director
Ms. Racquel Harris Mason
Chief Marketing Officer & Executive Vice President
Mr. James M. Meer
Chief Accounting Officer & Vice President
Mr. Fadi Debes
Vice President & Corporate Controller
Ms. Marcela A. Kirberger
Secretary & General Counsel
Dr. Ellen de Brabander
Vice President-Innovation & Regulatory Affairs
Mr. R. David Hoover
Independent Chairman
Mr. Paul S. Herendeen
Independent Director
Mr. Scott David Ferguson
Independent Director
Mr. William F. Doyle
Independent Director
Ms. Kapila Kapur Anand
Independent Director
Mr. Lawrence Erik Kurzius
Independent Director
Mr. John P. Bilbrey
Independent Director
Dr. Deborah Turner Kochevar
Independent Director
Mr. Kirk P. McDonald
Independent Director
Dr. Denise Vera Scots-Knight
Independent Director
Mr. Art A. Garcia
Independent Director
Trending Tickers
  • /zigman2/quotes/200467500/composite NVDA+6.01%
  • /zigman2/quotes/200164174/composite SNOA+85.40%
  • /zigman2/quotes/202092269/composite ENSC+35.46%
  • /zigman2/quotes/226465160/composite ALF-14.72%
  • /zigman2/quotes/207732364/composite MSFT+1.66%
X
Powered by StockTwits
Link to MarketWatch's Slice.